These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8273372

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G.
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of chronic viral hepatitis].
    Sperl J.
    Vnitr Lek; 1995 Mar; 41(3):182-4. PubMed ID: 7762176
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G, Naoumov NV, Williams R.
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [Abstract] [Full Text] [Related]

  • 31. Long term treatment of chronic delta hepatitis with alpha recombinant interferon.
    Marinucci G, Hassan G, Di Giacomo C, Barlattani A, Costa F, Rasshofer R, Roggendorf M.
    Prog Clin Biol Res; 1991 Nov; 364():405-10. PubMed ID: 2020716
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F, Sata M, Uchimura Y, Suzuki H, Tanikawa K.
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [Abstract] [Full Text] [Related]

  • 35. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
    Kuloglu Z, Krsaçloglu CT, Kansu A, Erden E, Girgin N.
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
    [Abstract] [Full Text] [Related]

  • 36. Danshao huaxian capsule in treatment of decompensated cirrhosis resulting from chronic hepatitis B.
    Cheng ML, Lu T, Yao YM, Geng XX.
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):48-51. PubMed ID: 16481282
    [Abstract] [Full Text] [Related]

  • 37. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC, Maran E, Saracco G, Rosina F, Baldi M, Brunetto M.
    Prog Clin Biol Res; 1987 Feb; 234():305-8. PubMed ID: 3628385
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunological markers in patients with different forms of viral hepatitis B treated by "conventional" therapy or with HuIFN alpha.
    Stancek D, Janota S, Blaskovicová H, Hajnická V, Laktis K, Sudová J, Cvopová A, Klement C.
    Acta Virol; 1990 Sep; 34(5):467-76. PubMed ID: 1981457
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.